Daniel Gerlach
Impact in
- Aging top 5%
- Molecular Biology top 5%
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- CRISPR and Genetic Engineering
- RNA modifications and cancer
Papers in
-
- Protein Degradation and Inhibitors 9
- RNA and protein synthesis mechanisms 5
- RNA Research and Splicing 4
- Genomics and Chromatin Dynamics 4
- Oncology 7
- Co-authors
- Alexander Stark (6 shared papers)Cosmas D. Arnold (4 shared papers)Martina Rath (3 shared papers)Łukasz M. Boryń (3 shared papers)Christoph Stelzer (2 shared papers)Evgeny M. Zdobnov (7 shared papers)Tobias Müller (2 shared papers)Matthias Wolf (2 shared papers)
- Journals
- Cancer Research (7 papers)Molecular Cancer Therapeutics (3 papers)PLoS ONE (3 papers)European Journal of Cancer (2 papers)RNA (2 papers)
- Partner nations
- AustriaUnited StatesSwitzerland
In The Last Decade
Daniel Gerlach
40 papers receiving 2.7k citations
Daniel Gerlach's Hit Papers
Peers
Comparison fields: 5 of 107
- Aging 59
- Molecular Biology 1.8k
- Cancer Research 313
- Endocrine and Autonomic Systems 105
- Cardiology and Cardiovascular Medicine 331
Countries citing papers authored by Daniel Gerlach
This map shows the geographic impact of Daniel Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Gerlach more than expected).
Fields of papers citing papers by Daniel Gerlach
This network shows the impact of papers produced by Daniel Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Gerlach. The network helps show where Daniel Gerlach may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Gerlach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genome-Wide Quantitative Enhancer Activity Maps Identified by STARR-seq Hit paper breakdown → | 2013 | 760 |
| 2 | 2009 | 330 | |
| 3 | 2005 | 322 | |
| 4 | 2014 | 126 | |
| 5 | 2009 | 120 | |
| 6 | 2014 | 110 | |
| 7 | 2011 | 104 | |
| 8 | 2014 | 102 | |
| 9 | 2012 | 85 | |
| 10 | 2021 | 69 | |
| 11 | 2008 | 69 | |
| 12 | 2018 | 66 | |
| 13 | 2015 | 65 | |
| 14 | 2007 | 62 | |
| 15 | 2008 | 52 | |
| 16 | 2018 | 48 | |
| 17 | 2014 | 46 | |
| 18 | 2016 | 45 | |
| 19 | 2010 | 43 | |
| 20 | 2021 | 40 |
About Daniel Gerlach
Daniel Gerlach is a scholar working on Molecular Biology, Oncology, Cardiology and Cardiovascular Medicine, Hematology and Genetics, having authored 43 papers that have together received 2.8k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (9 papers), Multiple Myeloma Research and Treatments (5 papers), RNA and protein synthesis mechanisms (5 papers), Viral Infections and Immunology Research (5 papers), RNA Research and Splicing (4 papers), Respiratory viral infections research (4 papers), Genomics and Chromatin Dynamics (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). The work is most often cited by research in Aging (59 citations), Molecular Biology (1.8k citations), Cancer Research (313 citations), Endocrine and Autonomic Systems (105 citations) and Cardiology and Cardiovascular Medicine (331 citations). Daniel Gerlach has collaborated with scholars based in Austria, United States and Switzerland. Frequent co-authors include Alexander Stark, Cosmas D. Arnold, Martina Rath, Łukasz M. Boryń, Christoph Stelzer, Evgeny M. Zdobnov, Tobias Müller, Matthias Wolf, Jörg Schultz and Caroline Tapparel. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, PLoS ONE, European Journal of Cancer and RNA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.